Ondansetron Injection, Solution
Product Images NDC 0409-0009

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 0409-0009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetron 01)

FDA Label Image

Logo (Ondansetron 02)

FDA Label Image

Principal Display Panel (2 mL Vial Label)

This is a 2mL single-dose vial of ondansetron injection USP, with a concentration of 2mg/mL. It should be protected from light and is distributed by Hospira, Inc. located in Lake Forest, USA. The product code is NDC 0409-0009-02, and the identifier at the end of the text is PAA226350.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

This is a product description for Ondansetron Injection, USP. Each 1 mL of the aqueous solution contains 2 mg of ondansetron hydrochloride dihydrate, 90 mg of sodium chloride, 0.46 mg of citric acid anhydrous, and 0.25 mg of sodium citrate dihydrate as buffers. The product is packaged in sterile flip-top vials in a presentation of 25x2mL single-dose units. The product is typically identified by the codes PAA226421 and NDC0403.000925.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.